Policy / Regulatory

Shanghai Unveils Policies to Boost Global Biomedical R&D Hub

Company

WuXi Biologics Launches Integrated Biologics CRDMO Center in Shanghai

CompanyDeals

Nona Biosciences Licenses HCAb Technology to Dragonfly Therapeutics

CompanyDrug

Salubris Pharmaceuticals’ SAL0119 Accepted for CDE Review in China

CompanyDrug

Aosaikang’s ASKG915 Accepted for FDA Review, Targets Advanced Solid Tumors

CompanyDrug

Legend Biotech Receives IND Approval for LB2102 CAR-T Therapy

CompanyDrug

Sun-Novo Pharma Gains NMPA Approval for STC007 Clinical Study in CKD-aP

CompanyDeals

JD Healthcare Partners with Jiangsu Yuyue for Medical Device Collaboration

CompanyDrug

Junshi Biosciences’ JunMaiKang Approved by NMPA for Multiple Indications

CompanyDrug

Hengrui Pharmaceuticals Receives FDA ANDA Approval for Gadobutrol Generic

CompanyDrug

Fosun Pharma’s Bivalent COVID-19 Vaccine Comirnaty Authorized in Hong Kong

CompanyDrug

IASO Biotherapeutics Reports Positive Phase I Results for CAR-T Therapy in NMOSD